4//SEC Filing
Krishnamohan Neha 4
Accession 0001866171-25-000007
CIK 0001787306other
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 7:56 PM ET
Size
14.1 KB
Accession
0001866171-25-000007
Insider Transaction Report
Form 4
Krishnamohan Neha
Director
Transactions
- Exercise/Conversion
Common Stock
2025-11-13$7.51/sh+12,220$91,772→ 62,627 total - Exercise/Conversion
Stock Option (right to buy)
2025-11-13−27,052→ 0 totalExercise: $8.63Exp: 2034-06-14→ Common Stock (27,052 underlying) - Exercise/Conversion
Common Stock
2025-11-13$8.63/sh+27,052$233,459→ 50,407 total - Sale
Common Stock
2025-11-13$23.19/sh−39,272$910,702→ 23,355 total - Sale
Common Stock
2025-11-13$23.37/sh−1,232$28,792→ 22,123 total - Exercise/Conversion
Stock Option (right to buy)
2025-11-13−12,220→ 0 totalExercise: $7.51Exp: 2033-05-31→ Common Stock (12,220 underlying)
Footnotes (4)
- [F1]The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted on August 14, 2025, by the Reporting Person, with a plan end date of November 2, 2026.
- [F2]The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $22.86 to $23.60, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of June 14, 2024, subject to the non-employee director's continuous service.
- [F4]The underlying shares subject to the option vest and become exercisable as to 100% on the first anniversary of May 31, 2023.
Documents
Issuer
Arcutis Biotherapeutics, Inc.
CIK 0001787306
Entity typeother
Related Parties
1- filerCIK 0001866171
Filing Metadata
- Form type
- 4
- Filed
- Nov 16, 7:00 PM ET
- Accepted
- Nov 17, 7:56 PM ET
- Size
- 14.1 KB